According to the Zhitong Finance App, Hengrui Pharmaceutical (01276.HK) issued an announcement to spend 8.971 million yuan to repurchase 195,000 A-shares on October 16, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.